[S02DA03, antipyrine, The risk or severity of bleeding can be increased when Zidovudine is combined with Antipyrine.]
[B01AD01, streptokinase, The risk or severity of bleeding can be increased when Streptokinase is combined with Zidovudine.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Zidovudine.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Zidovudine.]
[L04AA27, fingolimod, Zidovudine may increase the immunosuppressive activities of Fingolimod.]
[J01EC02, sulfadiazine, The metabolism of Zidovudine can be decreased when combined with Sulfadiazine.]
[S01AB01, sulfamethizole, The metabolism of Zidovudine can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Zidovudine.]
[J01EC03, sulfamoxole, The metabolism of Zidovudine can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Zidovudine can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Zidovudine can be decreased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The metabolism of Zidovudine can be decreased when combined with Sulfisoxazole.]
[M01AB02, sulindac, The risk or severity of bleeding can be increased when Zidovudine is combined with Sulindac.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Zidovudine.]
[M01AX04, apazone, The risk or severity of bleeding can be increased when Zidovudine is combined with Azapropazone.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Mercaptopurine.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Zidovudine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Zidovudine.]
[L01CB02, teniposide, The risk or severity of adverse effects can be increased when Teniposide is combined with Zidovudine.]
[B01AE07, dabigatran etexilate, The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Zidovudine.]
[G03BA03, testosterone, The excretion of Zidovudine can be increased when combined with Testosterone.]
[S03AA02, tetracycline, The excretion of Tetracycline can be decreased when combined with Zidovudine.]
[A04AD10, dronabinol, The metabolism of Zidovudine can be decreased when combined with Dronabinol.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be decreased when combined with Zidovudine.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Thalidomide.]
[R03DA04, theophylline, The metabolism of Zidovudine can be decreased when combined with Theophylline.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Eribulin.]
[L01AC01, thiotepa, The risk or severity of adverse effects can be increased when Zidovudine is combined with Thiotepa.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Zidovudine.]
[B01AC05, ticlopidine, The risk or severity of bleeding can be increased when Ticlopidine is combined with Zidovudine.]
[A10BB05, tolazamide, The metabolism of Tolazamide can be decreased when combined with Zidovudine.]
[V04CA01, tolbutamide, The metabolism of Tolbutamide can be decreased when combined with Zidovudine.]
[M02AA21, tolmetin, The risk or severity of bleeding can be increased when Zidovudine is combined with Tolmetin.]
[N02AX02, tramadol, The metabolism of Tramadol can be increased when combined with Zidovudine.]
[N06AF04, tranylcypromine, The metabolism of Zidovudine can be decreased when combined with Tranylcypromine.]
[C01DX11, trapidil, The risk or severity of bleeding can be increased when Trapidil is combined with Zidovudine.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Tretinoin.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Triamcinolone.]
[N05CD05, triazolam, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Triazolam.]
[C03AA06, trichlormethiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Zidovudine.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Zidovudine.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluclorolone.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Mometasone.]
[N03AC02, trimethadione, The metabolism of Zidovudine can be decreased when combined with Trimethadione.]
[J01EA01, trimethoprim, The metabolism of Zidovudine can be decreased when combined with Trimethoprim.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Zidovudine.]
[J01FA08, troleandomycin, The metabolism of Zidovudine can be decreased when combined with Troleandomycin.]
[R03DX07, roflumilast, Roflumilast may increase the immunosuppressive activities of Zidovudine.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Belimumab.]
[L01EX04, vandetanib, Vandetanib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L02BX03, abiraterone, The metabolism of Zidovudine can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Zidovudine can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Zidovudine can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Zidovudine can be decreased when combined with Telaprevir.]
[B01AD04, urokinase, The risk or severity of bleeding can be increased when Urokinase is combined with Zidovudine.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Zidovudine is combined with Belatacept.]
[N03AX21, ezogabine, The metabolism of Ezogabine can be increased when combined with Zidovudine.]
[B01AF01, rivaroxaban, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Zidovudine.]
[R03AC18, indacaterol, The metabolism of Indacaterol can be increased when combined with Zidovudine.]
[B01AC24, ticagrelor, The risk or severity of bleeding can be increased when Ticagrelor is combined with Zidovudine.]
[C08DA01, verapamil, The metabolism of Zidovudine can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Zidovudine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Vinblastine.]
[L01CA02, vincristine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Vincristine.]
[L01CA03, vindesine, The risk or severity of adverse effects can be increased when Vindesine is combined with Zidovudine.]
[B03BA01, vitamin B12, The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Zidovudine.]
[B01AA03, warfarin, The risk or severity of bleeding can be increased when Warfarin is combined with Zidovudine.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Antilymphocyte immunoglobulin (horse).]
[S01AA13, fusidic acid, The metabolism of Fusidic acid can be increased when combined with Zidovudine.]
[J05AE02, indinavir, The metabolism of Zidovudine can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, Vemurafenib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Zidovudine.]
[L01FX05, brentuximab vedotin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Brentuximab vedotin.]
[L01ED01, crizotinib, The metabolism of Zidovudine can be decreased when combined with Crizotinib.]
[B01AE01, desirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Zidovudine.]
[R03DC01, zafirlukast, The metabolism of Zidovudine can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ibandronate.]
[N05AE04, ziprasidone, The metabolism of Zidovudine can be decreased when combined with Ziprasidone.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Zidovudine.]
[N02BA01, aspirin, The risk or severity of bleeding can be increased when Zidovudine is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ruxolitinib.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Zidovudine.]
[J01DH04, doripenem, The excretion of Doripenem can be decreased when combined with Zidovudine.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Zidovudine.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Zidovudine.]
[J02AC03, voriconazole, The metabolism of Zidovudine can be decreased when combined with Voriconazole.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be increased when combined with Zidovudine.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Zidovudine is combined with Prednylidene.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Azacitidine.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Azathioprine.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Zidovudine.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Zidovudine.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Zidovudine.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Zidovudine.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Zidovudine.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Zidovudine.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Carfilzomib.]
[V03AX03, cobicistat, The metabolism of Zidovudine can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Zidovudine can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Zidovudine can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Bosutinib.]
[L04AA31, teriflunomide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Teriflunomide.]
[B01AX01, defibrotide, The risk or severity of bleeding can be increased when Defibrotide is combined with Zidovudine.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Zidovudine is combined with Abetimus.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Aldosterone.]
[L01EX05, regorafenib, Regorafenib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Zidovudine can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Bendamustine.]
[C08CA13, lercanidipine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Lercanidipine.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Zidovudine.]
[L04AA29, tofacitinib, Zidovudine may increase the immunosuppressive activities of Tofacitinib.]
[L01EX07, cabozantinib, The metabolism of Zidovudine can be decreased when combined with Cabozantinib.]
[G04BE03, sildenafil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Zidovudine.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Zidovudine.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Zidovudine.]
[C03AA01, bendroflumethiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Zidovudine.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Pomalidomide.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Zidovudine.]
[N02BA10, benorilate, The risk or severity of bleeding can be increased when Zidovudine is combined with Benorilate.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Zidovudine is combined with Dimethyl fumarate.]
[M04AB03, benzbromarone, The metabolism of Zidovudine can be decreased when combined with Benzbromarone.]
[A06AX06, tegaserod, The metabolism of Zidovudine can be decreased when combined with Tegaserod.]
[J02AX04, caspofungin, The excretion of Zidovudine can be decreased when combined with Caspofungin.]
[M01AH01, celecoxib, The risk or severity of bleeding can be increased when Zidovudine is combined with Celecoxib.]
[L04AA18, everolimus, The risk or severity of adverse effects can be increased when Zidovudine is combined with Everolimus.]
[L03AB03, gamma-interferon, The risk or severity of adverse effects can be increased when Interferon Gamma is combined with Zidovudine.]
[L01EC02, dabrafenib, The serum concentration of Zidovudine can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The risk or severity of bleeding can be increased when Zidovudine is combined with Benzydamine.]
[L01EE01, trametinib, The metabolism of Zidovudine can be decreased when combined with Trametinib.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Zidovudine.]
[L01EB03, afatinib, Afatinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Zidovudine.]
[J05AJ03, dolutegravir, The excretion of Zidovudine can be decreased when combined with Dolutegravir.]
[C02KX05, riociguat, The metabolism of Riociguat can be decreased when combined with Zidovudine.]
[L03AA14, lipegfilgrastim, Zidovudine may increase the myelosuppressive activities of Lipegfilgrastim.]
[A05AA03, cholic acid, The excretion of Cholic Acid can be decreased when combined with Zidovudine.]
[G03XC02, bazedoxifene, The metabolism of Bazedoxifene can be increased when combined with Zidovudine.]
[L01EL01, ibrutinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ibrutinib.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Zidovudine.]
[N03AF04, eslicarbazepine, The metabolism of Eslicarbazepine can be increased when combined with Zidovudine.]
[J05AP05, simeprevir, The metabolism of Zidovudine can be decreased when combined with Simeprevir.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Zidovudine.]
[A16AA07, metreleptin, The metabolism of Zidovudine can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Zidovudine can be increased when combined with Apremilast.]
[S03BA03, betamethasone, The risk or severity of adverse effects can be increased when Betamethasone is combined with Zidovudine.]
[B01AE03, argatroban, The risk or severity of bleeding can be increased when Argatroban is combined with Zidovudine.]
[V03AB34, fomepizole, The metabolism of Zidovudine can be decreased when combined with Fomepizole.]
[C10AB02, bezafibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Bezafibrate.]
[L04AC11, siltuximab, The metabolism of Zidovudine can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Zidovudine can be decreased when combined with Ceritinib.]
[B01AC26, vorapaxar, The risk or severity of bleeding can be increased when Vorapaxar is combined with Zidovudine.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Vedolizumab.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Acenocoumarol is combined with Zidovudine.]
[L01XH04, belinostat, The metabolism of Belinostat can be increased when combined with Zidovudine.]
[L01EM01, idelalisib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Idelalisib.]
[N07XX08, tafamidis, The serum concentration of Zidovudine can be increased when it is combined with Tafamidis.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Zidovudine.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Zidovudine is combined with Peginterferon beta-1a.]
[J01XA05, oritavancin, The metabolism of Zidovudine can be decreased when combined with Oritavancin.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Decitabine.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Pirfenidone.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be increased when combined with Zidovudine.]
[S03AA06, gentamicin, The excretion of Zidovudine can be decreased when combined with Gentamicin.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Blinatumomab.]
[J05AP09, dasabuvir, Dasabuvir may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L01XK01, olaparib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Olaparib.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Dicoumarol is combined with Zidovudine.]
[B01AF03, edoxaban, The risk or severity of bleeding can be increased when Edoxaban is combined with Zidovudine.]
[L04AC10, secukinumab, The metabolism of Zidovudine can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Palbociclib.]
[L01EX08, lenvatinib, The excretion of Zidovudine can be decreased when combined with Lenvatinib.]
[L01XH03, panobinostat, The risk or severity of adverse effects can be increased when Zidovudine is combined with Panobinostat.]
[J05AP07, daclatasvir, Daclatasvir may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N02BE01, acetaminophen, The metabolism of Zidovudine can be decreased when combined with Acetaminophen.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Zidovudine.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Tioclomarol is combined with Zidovudine.]
[J05AF08, adefovir dipivoxil, The excretion of Zidovudine can be decreased when combined with Adefovir dipivoxil.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Zidovudine.]
[A07DA06, eluxadoline, The excretion of Eluxadoline can be decreased when combined with Zidovudine.]
[B01AC25, cangrelor, The risk or severity of bleeding can be increased when Cangrelor is combined with Zidovudine.]
[A04AD14, rolapitant, Rolapitant may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[M02AA25, aceclofenac, The risk or severity of bleeding can be increased when Zidovudine is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of bleeding can be increased when Zidovudine is combined with Acemetacin.]
[S01EC01, acetazolamide, The excretion of Zidovudine can be decreased when combined with Acetazolamide.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Acipimox.]
[A02BC03, lansoprazole, The excretion of Zidovudine can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Trabectedin.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Mepolizumab.]
[J02AC05, isavuconazole, The metabolism of Zidovudine can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, Osimertinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The excretion of Tenofovir alafenamide can be decreased when combined with Zidovudine.]
[L01ED03, alectinib, Alectinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Zidovudine.]
[A10BB31, acetohexamide, The metabolism of Zidovudine can be decreased when combined with Acetohexamide.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Zidovudine.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[M01AE16, alminoprofen, The risk or severity of bleeding can be increased when Zidovudine is combined with Alminoprofen.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Zidovudine.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ixekizumab.]
[L01XX52, venetoclax, The metabolism of Zidovudine can be decreased when combined with Venetoclax.]
[C03CA02, bumetanide, The excretion of Bumetanide can be decreased when combined with Zidovudine.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be increased when combined with Zidovudine.]
[L01AB01, busulfan, The risk or severity of adverse effects can be increased when Zidovudine is combined with Busulfan.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Arsenic trioxide.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Zidovudine.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Zidovudine.]
[L01XK03, rucaparib, Rucaparib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Brodalumab.]
[L01EF02, ribociclib, The metabolism of Zidovudine can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of bleeding can be increased when Zidovudine is combined with Balsalazide.]
[L04AA36, ocrelizumab, Ocrelizumab may increase the immunosuppressive activities of Zidovudine.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Zidovudine.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Zidovudine is combined with Linezolid.]
[J05AE09, tipranavir, The metabolism of Zidovudine can be decreased when combined with Tipranavir.]
[L04AB02, infliximab, The metabolism of Zidovudine can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Zidovudine can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Zidovudine.]
[N04BD03, safinamide, Safinamide may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Sarilumab.]
[J01MA23, delafloxacin, The metabolism of Delafloxacin can be increased when combined with Zidovudine.]
[B01AF04, betrixaban, The risk or severity of bleeding can be increased when Betrixaban is combined with Zidovudine.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Guselkumab.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Zidovudine.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Zidovudine is combined with Vorinostat.]
[L01EF03, abemaciclib, Abemaciclib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[J05AG03, efavirenz, The metabolism of Zidovudine can be decreased when combined with Efavirenz.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Zidovudine.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Zidovudine.]
[V03AF08, palifermin, The therapeutic efficacy of Palifermin can be decreased when used in combination with Zidovudine.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Budesonide.]
[C04AX20, buflomedil, The risk or severity of bleeding can be increased when Buflomedil is combined with Zidovudine.]
[M01AB07, bumadizone, The risk or severity of bleeding can be increased when Zidovudine is combined with Bumadizone.]
[J05AX18, letermovir, The excretion of Zidovudine can be decreased when combined with Letermovir.]
[A10BK04, ertugliflozin, The metabolism of Zidovudine can be decreased when combined with Ertugliflozin.]
[C09AA01, captopril, The excretion of Captopril can be decreased when combined with Zidovudine.]
[L02BB05, apalutamide, The metabolism of Zidovudine can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Carbamazepine.]
[J01CA03, carbenicillin, The excretion of Zidovudine can be decreased when combined with Carbenicillin.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Zidovudine.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Zidovudine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be increased when combined with Zidovudine.]
[B02BX09, fostamatinib, Fostamatinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N03AX24, cannabidiol, Cannabidiol may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[B02BX08, avatrombopag, The excretion of Zidovudine can be decreased when combined with Avatrombopag.]
[L04AA37, baricitinib, The serum concentration of Baricitinib can be increased when it is combined with Zidovudine.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be increased when combined with Zidovudine.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Zidovudine.]
[H01CC03, elagolix, The metabolism of Elagolix can be increased when combined with Zidovudine.]
[L01XX62, ivosidenib, The metabolism of Zidovudine can be increased when combined with Ivosidenib.]
[A16AX14, migalastat, The metabolism of Migalastat can be increased when combined with Zidovudine.]
[N03AX17, stiripentol, The metabolism of Zidovudine can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Zidovudine can be increased when combined with Tecovirimat.]
[L01EB07, dacomitinib, Dacomitinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Zidovudine.]
[M01AC05, lornoxicam, The risk or severity of bleeding can be increased when Zidovudine is combined with Lornoxicam.]
[L04AA39, emapalumab, The metabolism of Zidovudine can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Zidovudine.]
[L01EX13, gilteritinib, Gilteritinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L01XJ03, glasdegib, Glasdegib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ravulizumab.]
[B01AX07, caplacizumab, The risk or severity of bleeding can be increased when Caplacizumab is combined with Zidovudine.]
[B01AC23, cilostazol, The risk or severity of bleeding can be increased when Cilostazol is combined with Zidovudine.]
[C10AB08, ciprofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ciprofibrate.]
[P02BX04, triclabendazole, The metabolism of Zidovudine can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Esketamine can be decreased when combined with Zidovudine.]
[L04AA42, siponimod, The risk or severity of adverse effects can be increased when Zidovudine is combined with Siponimod.]
[J01FA09, clarithromycin, Clarithromycin may increase the myelosuppressive activities of Zidovudine.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Zidovudine.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Zidovudine is combined with Cloprednol.]
[C01EB09, ubidecarenone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ubidecarenone.]
[C09CA06, candesartan, The metabolism of Zidovudine can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Zidovudine can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Zidovudine is combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Risankizumab.]
[L01EM03, alpelisib, The serum concentration of Zidovudine can be decreased when it is combined with Alpelisib.]
[J01DC04, cefaclor, The excretion of Cefaclor can be decreased when combined with Zidovudine.]
[J01DB05, cefadroxil, The excretion of Zidovudine can be decreased when combined with Cefadroxil.]
[J01DC03, cefamandole, The excretion of Zidovudine can be decreased when combined with Cefamandole.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Zidovudine.]
[L02BB06, darolutamide, The serum concentration of Zidovudine can be increased when it is combined with Darolutamide.]
[L01EX15, pexidartinib, The metabolism of Zidovudine can be decreased when combined with Pexidartinib.]
[J01DD12, cefoperazone, The excretion of Zidovudine can be decreased when combined with Cefoperazone.]
[J01DD01, cefotaxime, The excretion of Zidovudine can be decreased when combined with Cefotaxime.]
[J01DC07, cefotiam, The excretion of Zidovudine can be decreased when combined with Cefotiam.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Zidovudine.]
[J01DD04, ceftriaxone, The excretion of Zidovudine can be decreased when combined with Ceftriaxone.]
[L04AA44, upadacitinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Upadacitinib.]
[L01EJ02, fedratinib, Fedratinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N07XX11, pitolisant, The serum concentration of Zidovudine can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, Istradefylline may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[C03AA09, cyclothiazide, The excretion of Zidovudine can be decreased when combined with Cyclothiazide.]
[J01XX09, daptomycin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Zidovudine.]
[J01DB01, cephalexin, The excretion of Cephalexin can be decreased when combined with Zidovudine.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Zidovudine.]
[J01DB03, cephalothin, The excretion of Zidovudine can be decreased when combined with Cefalotin.]
[J01DB09, cephradine, The excretion of Zidovudine can be decreased when combined with Cefradine.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Zidovudine is combined with Deflazacort.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Zidovudine.]
[L01FD03, ado-trastuzumab emtansine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Trastuzumab emtansine.]
[N02CC08, lasmiditan, The serum concentration of Zidovudine can be increased when it is combined with Lasmiditan.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Zidovudine is combined with Diroximel fumarate.]
[G03AC09, desogestrel, The metabolism of Zidovudine can be increased when combined with Desogestrel.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Zidovudine.]
[N03AX25, cenobamate, The serum concentration of Zidovudine can be decreased when it is combined with Cenobamate.]
[L01EX18, avapritinib, The metabolism of Zidovudine can be decreased when combined with Avapritinib.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Teprotumumab.]
[N05AD10, lumateperone, The metabolism of Lumateperone can be increased when combined with Zidovudine.]
[M01AX21, diacetylrhein, The metabolism of Zidovudine can be decreased when combined with Diacerein.]
[J05AE05, amprenavir, The metabolism of Zidovudine can be decreased when combined with Amprenavir.]
[L04AA38, ozanimod, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ozanimod.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be increased when combined with Zidovudine.]
[N02CC06, eletriptan, The metabolism of Zidovudine can be increased when combined with Eletriptan.]
[M01AH02, rofecoxib, The risk or severity of bleeding can be increased when Zidovudine is combined with Rofecoxib.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Bexarotene is combined with Zidovudine.]
[C08CA16, clevidipine, The metabolism of Zidovudine can be decreased when combined with Clevidipine.]
[C01BD07, dronedarone, The excretion of Zidovudine can be decreased when combined with Dronedarone.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Zidovudine.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Zidovudine.]
[L01FX17, sacituzumab govitecan, The serum concentration of Sacituzumab govitecan can be decreased when it is combined with Zidovudine.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Zidovudine.]
[L01EX17, capmatinib, The serum concentration of Zidovudine can be increased when it is combined with Capmatinib.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluprednidene.]
[M01AC04, droxicam, The risk or severity of bleeding can be increased when Zidovudine is combined with Droxicam.]
[L01EX19, ripretinib, Ripretinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L01EX22, selpercatinib, The serum concentration of Zidovudine can be increased when it is combined with Selpercatinib.]
[B01AE02, lepirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Zidovudine.]
[M02AA27, dexketoprofen, The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Zidovudine.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be decreased when combined with Zidovudine.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Zidovudine is combined with Inebilizumab.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Stepronin.]
[J05AX29, fostemsavir, Fostemsavir may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Zidovudine.]
[L04AC19, satralizumab, The serum concentration of Zidovudine can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Chloroquine.]
[L01EX23, pralsetinib, Pralsetinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[C03AA04, chlorothiazide, The excretion of Zidovudine can be decreased when combined with Chlorothiazide.]
[A10BB02, chlorpropamide, The excretion of Zidovudine can be decreased when combined with Chlorpropamide.]
[M03BB03, chlorzoxazone, The metabolism of Zidovudine can be decreased when combined with Chlorzoxazone.]
[N02BA07, ethenzamide, The risk or severity of bleeding can be increased when Zidovudine is combined with Ethenzamide.]
[M01AB08, etodolac, The risk or severity of bleeding can be increased when Zidovudine is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of bleeding can be increased when Zidovudine is combined with Etofenamate.]
[C10AB09, etofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Etofibrate.]
[B06AC06, berotralstat, The metabolism of Zidovudine can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Zidovudine can be decreased when combined with Lonafarnib.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fludarabine.]
[J05AJ04, cabotegravir, The excretion of Zidovudine can be decreased when combined with Cabotegravir.]
[L04AD03, voclosporin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Voclosporin.]
[P03AX07, abametapir, The serum concentration of Zidovudine can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The metabolism of Zidovudine can be decreased when combined with Tepotinib.]
[N03AX10, felbamate, The metabolism of Zidovudine can be decreased when combined with Felbamate.]
[M01AE05, fenbufen, The risk or severity of bleeding can be increased when Zidovudine is combined with Fenbufen.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Zidovudine.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Zidovudine.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluocinolone acetonide.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Zidovudine.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Zidovudine.]
[L04AA50, ponesimod, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ponesimod.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Zidovudine.]
[A02BA01, cimetidine, The excretion of Cimetidine can be decreased when combined with Zidovudine.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Zidovudine.]
[J01MB06, cinoxacin, The excretion of Zidovudine can be decreased when combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Zidovudine can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Zidovudine can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Cisplatin.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Zidovudine is combined with Pegcetacoplan.]
[C03DA05, finerenone, The metabolism of Finerenone can be decreased when combined with Zidovudine.]
[L04AA48, belumosudil, The risk or severity of adverse effects can be increased when Zidovudine is combined with Belumosudil.]
[P01CA03, fexinidazole, The excretion of Zidovudine can be decreased when combined with Fexinidazole.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Anifrolumab.]
[M01AG01, mefenamic acid, The risk or severity of bleeding can be increased when Zidovudine is combined with Mefenamic acid.]
[A10BB12, glimepiride, The metabolism of Zidovudine can be decreased when combined with Glimepiride.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Zidovudine.]
[N06AX25, St. John's wort extract, The metabolism of Zidovudine can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Zidovudine can be decreased when combined with Asciminib.]
[J05AX10, maribavir, Maribavir may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Zidovudine.]
[J04BA01, clofazimine, Clofazimine may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[B01AD11, tenecteplase, The risk or severity of bleeding can be increased when Tenecteplase is combined with Zidovudine.]
[C10AB01, clofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Zidovudine can be increased when combined with Mitapivat.]
[L01EJ03, pacritinib, The serum concentration of Zidovudine can be increased when it is combined with Pacritinib.]
[C01EB24, mavacamten, The serum concentration of Zidovudine can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, The excretion of Oseltamivir can be decreased when combined with Zidovudine.]
[J02AC06, oteseconazole, The serum concentration of Zidovudine can be increased when it is combined with Oteseconazole.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Deucravacitinib.]
[H01CC04, linzagolix, The serum concentration of Zidovudine can be increased when it is combined with Linzagolix.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Zidovudine.]
[J05AX31, lenacapavir, The metabolism of Lenacapavir can be increased when combined with Zidovudine.]
[N05AH02, clozapine, The risk or severity of neutropenia can be increased when Zidovudine is combined with Clozapine.]
[A10BK06, sotagliflozin, Sotagliflozin may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Zidovudine can be increased when combined with Somatrogon.]
[L04AC21, bimekizumab, The metabolism of Zidovudine can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of bleeding can be increased when Zidovudine is combined with Proquazone.]
[R05DA04, codeine, The excretion of Zidovudine can be decreased when combined with Codeine.]
[M04AC01, colchicine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Colchicine.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Leflunomide.]
[A10BX03, nateglinide, The excretion of Zidovudine can be decreased when combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of bleeding can be increased when Zidovudine is combined with Imidazole salicylate.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Nelarabine.]
[J01FA15, telithromycin, The metabolism of Zidovudine can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ciclesonide.]
[B01AC10, indobufen, The risk or severity of bleeding can be increased when Zidovudine is combined with Indobufen.]
[J05AB14, valganciclovir, The risk or severity of cytopenia can be increased when Valganciclovir is combined with Zidovudine.]
[M01AH03, valdecoxib, The risk or severity of bleeding can be increased when Zidovudine is combined with Valdecoxib.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Zidovudine.]
[M01AH04, parecoxib, The risk or severity of bleeding can be increased when Zidovudine is combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Zidovudine can be decreased when combined with Itraconazole.]
[B01AB12, bemiparin, The risk or severity of bleeding can be increased when Bemiparin is combined with Zidovudine.]
[S01AD03, acyclovir, The risk or severity of adverse effects can be increased when Acyclovir is combined with Zidovudine.]
[M01AA06, kebuzone, The risk or severity of bleeding can be increased when Zidovudine is combined with Kebuzone.]
[L02BA03, fulvestrant, The metabolism of Fulvestrant can be increased when combined with Zidovudine.]
[L01EA01, imatinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Zidovudine can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, The excretion of Zidovudine can be decreased when combined with Esomeprazole.]
[N03AX09, lamotrigine, The metabolism of Lamotrigine can be increased when combined with Zidovudine.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Nafarelin.]
[M01AB09, lonazolac, The risk or severity of bleeding can be increased when Zidovudine is combined with Lonazolac.]
[R06AX13, loratadine, The metabolism of Zidovudine can be decreased when combined with Loratadine.]
[M02AA31, loxoprofen, The risk or severity of bleeding can be increased when Zidovudine is combined with Loxoprofen.]
[C08CA11, manidipine, The metabolism of Zidovudine can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Mebeverine.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Meprednisone.]
[R06AE03, cyclizine, The metabolism of Zidovudine can be decreased when combined with Cyclizine.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Zidovudine.]
[C03AA07, cyclopenthiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Zidovudine.]
[J05AF07, tenofovir disoproxil, The excretion of Tenofovir disoproxil can be decreased when combined with Zidovudine.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Zidovudine.]
[S01XA18, cyclosporine, Zidovudine may increase the immunosuppressive activities of Cyclosporine.]
[N06BA07, modafinil, The metabolism of Zidovudine can be decreased when combined with Armodafinil.]
[C10AA07, rosuvastatin, The excretion of Rosuvastatin can be decreased when combined with Zidovudine.]
[M02AA02, mofebutazone, The risk or severity of bleeding can be increased when Zidovudine is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of bleeding can be increased when Zidovudine is combined with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Zidovudine can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Cytarabine.]
[M01AH05, etoricoxib, The risk or severity of bleeding can be increased when Zidovudine is combined with Etoricoxib.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Dacarbazine.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Dactinomycin.]
[G03XA01, danazol, The metabolism of Zidovudine can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Zidovudine can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Daunorubicin.]
[A04AD11, nabilone, The metabolism of Zidovudine can be decreased when combined with Nabilone.]
[M01AX01, nabumetone, The risk or severity of bleeding can be increased when Zidovudine is combined with Nabumetone.]
[N06AX06, nefazodone, The metabolism of Zidovudine can be decreased when combined with Nefazodone.]
[L02BB02, nilutamide, The metabolism of Zidovudine can be decreased when combined with Nilutamide.]
[N03AG06, tiagabine, The metabolism of Tiagabine can be increased when combined with Zidovudine.]
[B01AX05, fondaparinux, The risk or severity of bleeding can be increased when Fondaparinux is combined with Zidovudine.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Zidovudine.]
[A07EC03, olsalazine, The risk or severity of bleeding can be increased when Zidovudine is combined with Olsalazine.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Desoximetasone.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Oxaliplatin.]
[M01AE12, oxaprozin, The risk or severity of bleeding can be increased when Zidovudine is combined with Oxaprozin.]
[S03BA01, dexamethasone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Zidovudine can be decreased when combined with Oxybutynin.]
[L04AB04, adalimumab, The metabolism of Zidovudine can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, Gefitinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N06BA02, dextroamphetamine, The metabolism of Zidovudine can be decreased when combined with Amphetamine.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Zidovudine.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Zidovudine.]
[N06AB05, paroxetine, The metabolism of Zidovudine can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Zidovudine can be decreased when combined with Clopidogrel.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Zidovudine.]
[S01BC03, diclofenac, The risk or severity of bleeding can be increased when Zidovudine is combined with Diclofenac.]
[J05AD01, foscarnet, The excretion of Zidovudine can be decreased when combined with Foscarnet.]
[A10BG03, pioglitazone, The metabolism of Zidovudine can be decreased when combined with Pioglitazone.]
[L01DC04, ixabepilone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Zidovudine.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Pirarubicin.]
[L02AA01, diethylstilbestrol, Diethylstilbestrol may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[C08CA03, isradipine, The metabolism of Zidovudine can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Difluocortolone.]
[N02BA11, diflunisal, The risk or severity of bleeding can be increased when Zidovudine is combined with Diflunisal.]
[C10AX09, ezetimibe, The metabolism of Ezetimibe can be increased when combined with Zidovudine.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Zidovudine.]
[N02AA03, hydromorphone, The metabolism of Zidovudine can be decreased when combined with Hydromorphone.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Zidovudine.]
[J05AE08, atazanavir, The metabolism of Zidovudine can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Zidovudine can be decreased when combined with Treprostinil.]
[C08DB01, diltiazem, The metabolism of Zidovudine can be decreased when combined with Diltiazem.]
[N02BB04, propyphenazone, The risk or severity of bleeding can be increased when Zidovudine is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of bleeding can be increased when Zidovudine is combined with Proglumetacin.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Zidovudine.]
[C05CA03, diosmin, The metabolism of Zidovudine can be decreased when combined with Diosmin.]
[R06AA02, diphenhydramine, The metabolism of Diphenhydramine can be decreased when combined with Zidovudine.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Zidovudine.]
[C09AA06, quinapril, The excretion of Quinapril can be decreased when combined with Zidovudine.]
[B01AC07, dipyridamole, The risk or severity of bleeding can be increased when Dipyridamole is combined with Zidovudine.]
[B01AD10, drotrecogin alfa, The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Zidovudine.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Zidovudine.]
[S01XA23, sirolimus, The risk or severity of adverse effects can be increased when Zidovudine is combined with Sirolimus.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Natalizumab.]
[S02AA12, rifamycin SV, The metabolism of Zidovudine can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Zidovudine can be increased when combined with Rifapentine.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Zidovudine.]
[L01EX01, sunitinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Sunitinib.]
[A04AD12, aprepitant, The metabolism of Zidovudine can be decreased when combined with Aprepitant.]
[L01XG01, bortezomib, The risk or severity of adverse effects can be increased when Bortezomib is combined with Zidovudine.]
[S01BC05, ketorolac, The risk or severity of bleeding can be increased when Zidovudine is combined with Ketorolac.]
[N02BA06, salsalate, The risk or severity of bleeding can be increased when Zidovudine is combined with Salsalate.]
[R03AC12, salmeterol, The metabolism of Zidovudine can be decreased when combined with Salmeterol.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Zidovudine.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Zidovudine.]
[L01DB01, doxorubicin, The risk or severity of adverse effects can be increased when Doxorubicin is combined with Zidovudine.]
[N06AB06, sertraline, The metabolism of Zidovudine can be decreased when combined with Sertraline.]
[N01AB08, sevoflurane, The metabolism of Sevoflurane can be decreased when combined with Zidovudine.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be increased when combined with Zidovudine.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Corticotropin.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Zidovudine.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Temozolomide.]
[M01AC02, tenoxicam, The risk or severity of bleeding can be increased when Zidovudine is combined with Tenoxicam.]
[D01BA02, terbinafine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Terbinafine.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Emetine.]
[N06AX14, tianeptine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Tianeptine.]
[C09AA02, enalapril, The excretion of Zidovudine can be decreased when combined with Enalapril.]
[M01AG02, tolfenamic acid, The risk or severity of bleeding can be increased when Zidovudine is combined with Tolfenamic acid.]
[C03CA04, torsemide, The metabolism of Zidovudine can be decreased when combined with Torasemide.]
[B01AC18, triflusal, The risk or severity of bleeding can be increased when Triflusal is combined with Zidovudine.]
[H02CA01, trilostane, The risk or severity of adverse effects can be increased when Zidovudine is combined with Trilostane.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Trofosfamide.]
[C05CA04, troxerutin, The risk or severity of bleeding can be increased when Troxerutin is combined with Zidovudine.]
[L01CA04, vinorelbine, The risk or severity of adverse effects can be increased when Vinorelbine is combined with Zidovudine.]
[N06AX16, venlafaxine, Venlafaxine may increase the excretion rate of Zidovudine which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA12, mepirodipine, The metabolism of Zidovudine can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Zidovudine can be decreased when combined with Epinephrine.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Zidovudine.]
[N05CF02, zolpidem, The metabolism of Zidovudine can be decreased when combined with Zolpidem.]
[M01AB04, zomepirac, The risk or severity of bleeding can be increased when Zidovudine is combined with Zomepirac.]
[N03AX15, zonisamide, The metabolism of Zonisamide can be increased when combined with Zidovudine.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Zidovudine.]
[B01AD03, anistreplase, The risk or severity of bleeding can be increased when Anistreplase is combined with Zidovudine.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Carboplatin.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Iloprost.]
[N02CA02, ergotamine, The metabolism of Zidovudine can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Zidovudine can be decreased when combined with Erythromycin.]
[A02BC02, pantoprazole, The excretion of Zidovudine can be decreased when combined with Pantoprazole.]
[G03CA03, estradiol, The excretion of Estradiol can be decreased when combined with Zidovudine.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Estramustine.]
[G03CA57, estrogens, conjugated (USP), The excretion of Zidovudine can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, The metabolism of Zidovudine can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluticasone furoate.]
[R03BA05, fluticasone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be increased when combined with Zidovudine.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be increased when combined with Zidovudine.]
[M01AC06, meloxicam, The risk or severity of bleeding can be increased when Zidovudine is combined with Meloxicam.]
[L01CB01, etoposide, The metabolism of Etoposide can be increased when combined with Zidovudine.]
[L04AD02, tacrolimus, Tacrolimus may increase the immunosuppressive activities of Zidovudine.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Nizatidine.]
[R06AX12, terfenadine, The metabolism of Zidovudine can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Bupropion can be decreased when combined with Zidovudine.]
[N06AB08, fluvoxamine, The metabolism of Zidovudine can be decreased when combined with Fluvoxamine.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Zidovudine.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Zidovudine.]
[C10AA03, pravastatin, The excretion of Zidovudine can be decreased when combined with Pravastatin.]
[M01CB01, gold sodium thiomalate, The metabolism of Zidovudine can be decreased when combined with Sodium aurothiomalate.]
[A05AA01, chenodeoxycholic acid, The metabolism of Zidovudine can be decreased when combined with Chenodeoxycholic acid.]
[B05AA05, dextran, The risk or severity of bleeding can be increased when Dextran is combined with Zidovudine.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Zidovudine.]
[A02BA03, famotidine, The excretion of Famotidine can be decreased when combined with Zidovudine.]
[A16AA01, levocarnitine, The excretion of Levocarnitine can be decreased when combined with Zidovudine.]
[C08CA02, felodipine, The metabolism of Zidovudine can be decreased when combined with Felodipine.]
[M01AE04, fenoprofen, The risk or severity of bleeding can be increased when Zidovudine is combined with Fenoprofen.]
[L03AB02, interferon-beta, The risk or severity of adverse effects can be increased when Human interferon beta is combined with Zidovudine.]
[B01AD05, plasmin, The risk or severity of bleeding can be increased when Fibrinolysin is combined with Zidovudine.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Clofarabine.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Zidovudine.]
[C01BC04, flecainide, The metabolism of Zidovudine can be decreased when combined with Flecainide.]
[N02BG04, floctafenine, The risk or severity of bleeding can be increased when Zidovudine is combined with Floctafenine.]
[J02AC01, fluconazole, The metabolism of Zidovudine can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Flucytosine.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fludrocortisone.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Zidovudine.]
[N05CD03, flunitrazepam, The metabolism of Zidovudine can be decreased when combined with Flunitrazepam.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluocinonide.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluocortolone.]
[V03AZ01, ethanol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ethanol.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Zidovudine.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Zidovudine.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Zidovudine.]
[N06AB03, fluoxetine, The metabolism of Zidovudine can be decreased when combined with Fluoxetine.]
[N05AF01, flupenthixol, The risk or severity of myelosuppression can be increased when Flupentixol is combined with Zidovudine.]
[N05CD01, flurazepam, The metabolism of Flurazepam can be decreased when combined with Zidovudine.]
[S01BC04, flurbiprofen, The risk or severity of bleeding can be increased when Zidovudine is combined with Flurbiprofen.]
[V04CX02, folic acid, The excretion of Zidovudine can be decreased when combined with Folic acid.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Zidovudine.]
[J05AE10, darunavir, The metabolism of Zidovudine can be decreased when combined with Darunavir.]
[C03CA01, furosemide, The excretion of Zidovudine can be decreased when combined with Furosemide.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Alendronic acid.]
[N05CF04, eszopiclone, The metabolism of Zidovudine can be decreased when combined with Eszopiclone.]
[S01AD09, ganciclovir, The excretion of Zidovudine can be decreased when combined with Ganciclovir.]
[C10AB04, gemfibrozil, The metabolism of Zidovudine can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Dasatinib.]
[J05AG04, etravirine, The metabolism of Zidovudine can be decreased when combined with Etravirine.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Zidovudine.]
[A10BB01, glyburide, The metabolism of Zidovudine can be decreased when combined with Glyburide.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Zidovudine.]
[A10BB07, glipizide, The metabolism of Glipizide can be increased when combined with Zidovudine.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Zidovudine.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Zidovudine.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Fluindione is combined with Zidovudine.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Zidovudine.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Zidovudine.]
[N01AB01, halothane, The metabolism of Halothane can be decreased when combined with Zidovudine.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be increased when combined with Zidovudine.]
[M04AA01, allopurinol, The risk or severity of adverse effects can be increased when Allopurinol is combined with Zidovudine.]
[C09CA01, losartan, The metabolism of Losartan can be increased when combined with Zidovudine.]
[S01XA14, heparin, The risk or severity of bleeding can be increased when Heparin is combined with Zidovudine.]
[A07EC02, mesalamine, The risk or severity of bleeding can be increased when Zidovudine is combined with Mesalazine.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Zidovudine.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Zidovudine.]
[C08CA10, nilvadipine, The metabolism of Zidovudine can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of bleeding can be increased when Zidovudine is combined with Nimesulide.]
[C03AA03, hydrochlorothiazide, The excretion of Hydrochlorothiazide can be decreased when combined with Zidovudine.]
[S02BA01, hydrocortisone, The excretion of Hydrocortisone can be decreased when combined with Zidovudine.]
[C03AA02, hydroflumethiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Zidovudine.]
[P01BA02, hydroxychloroquine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Hydroxychloroquine.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Zidovudine is combined with Hydroxyurea.]
[J04AB04, rifabutin, The metabolism of Zidovudine can be increased when combined with Rifabutin.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Risedronic acid.]
[R02AX02, ibuprofen, The risk or severity of bleeding can be increased when Zidovudine is combined with Ibuprofen.]
[B05CB02, sodium citrate, The risk or severity of bleeding can be increased when Sodium citrate is combined with Zidovudine.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Idarubicin.]
[L01AA06, ifosfamide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ifosfamide.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Zidovudine.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Zidovudine is combined with Tixocortol.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Zidovudine is combined with Topotecan.]
[S01BC01, indomethacin, The risk or severity of bleeding can be increased when Zidovudine is combined with Indomethacin.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Zidovudine.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Zidovudine.]
[N06AX17, milnacipran, The metabolism of Zidovudine can be decreased when combined with Milnacipran.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Eculizumab.]
[A10BH01, sitagliptin, The excretion of Sitagliptin can be decreased when combined with Zidovudine.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Zidovudine.]
[C10AA06, cerivastatin, The metabolism of Cerivastatin can be increased when combined with Zidovudine.]
[L01XX35, anagrelide, The risk or severity of bleeding can be increased when Anagrelide is combined with Zidovudine.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Zidovudine.]
[V03AB01, ipecac, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ipecac.]
[J05AF04, stavudine, The therapeutic efficacy of Stavudine can be decreased when used in combination with Zidovudine.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Zidovudine.]
[N06AF05, iproniazid, The metabolism of Zidovudine can be decreased when combined with Iproniazid.]
[P01AX06, atovaquone, The metabolism of Zidovudine can be decreased when combined with Atovaquone.]
[J04AC01, isoniazid, The metabolism of Zidovudine can be decreased when combined with Isoniazid.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Isotretinoin.]
[P02CF01, ivermectin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ivermectin.]
[B01AE06, bivalirudin, The risk or severity of bleeding can be increased when Bivalirudin is combined with Zidovudine.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Zidovudine.]
[L04AC07, tocilizumab, The metabolism of Zidovudine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Zidovudine.]
[C02KD01, ketanserin, The risk or severity of bleeding can be increased when Ketanserin is combined with Zidovudine.]
[B01AC22, prasugrel, The risk or severity of bleeding can be increased when Prasugrel is combined with Zidovudine.]
[J02AB02, ketoconazole, The metabolism of Zidovudine can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Zidovudine can be decreased when combined with Levoketoconazole.]
[N05AH03, olanzapine, The metabolism of Zidovudine can be decreased when combined with Olanzapine.]
[M02AA10, ketoprofen, The risk or severity of adverse effects can be increased when Ketoprofen is combined with Zidovudine.]
[V03AC03, deferasirox, The metabolism of Deferasirox can be increased when combined with Zidovudine.]
[L04AA24, abatacept, The metabolism of Zidovudine can be increased when combined with Abatacept.]
[J01MB02, nalidixic acid, The excretion of Zidovudine can be decreased when combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, The risk or severity of bleeding can be increased when Zidovudine is combined with Tiaprofenic acid.]
[C07AG01, labetalol, The metabolism of Labetalol can be increased when combined with Zidovudine.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Zidovudine.]
[C03CC01, ethacrynic acid, The excretion of Zidovudine can be decreased when combined with Etacrynic acid.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Zidovudine.]
[N06BA13, armodafinil, The metabolism of Zidovudine can be decreased when combined with Armodafinil.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Lomustine.]
[A07DA03, loperamide, The metabolism of Loperamide can be decreased when combined with Zidovudine.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be increased when combined with Zidovudine.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Zidovudine.]
[L01EG01, temsirolimus, The risk or severity of adverse effects can be increased when Zidovudine is combined with Temsirolimus.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Zidovudine is combined with Pralatrexate.]
[L01EA03, nilotinib, The metabolism of Zidovudine can be decreased when combined with Nilotinib.]
[L01AA05, mechlorethamine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Mechlorethamine.]
[M02AA18, meclofenamic acid, The risk or severity of bleeding can be increased when Zidovudine is combined with Meclofenamic acid.]
[P01BC02, mefloquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Zidovudine.]
[B01AB06, nadroparin, The risk or severity of bleeding can be increased when Nadroparin is combined with Zidovudine.]
[B01AB05, enoxaparin, The risk or severity of bleeding can be increased when Enoxaparin is combined with Zidovudine.]
[B01AB04, dalteparin, The risk or severity of bleeding can be increased when Dalteparin is combined with Zidovudine.]
[N05CH01, melatonin, The excretion of Zidovudine can be decreased when combined with Melatonin.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Zidovudine is combined with Melphalan.]
[N06DX01, memantine, The metabolism of Zidovudine can be decreased when combined with Memantine.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Zidovudine.]
[N07BC02, methadone, The serum concentration of Zidovudine can be increased when it is combined with Methadone.]
[S01EC05, methazolamide, The excretion of Zidovudine can be decreased when combined with Methazolamide.]
[H03BB02, methimazole, The metabolism of Zidovudine can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Zidovudine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[L04AX03, methotrexate, The risk or severity of adverse effects can be increased when Zidovudine is combined with Methotrexate.]
[D05BA02, methoxsalen, The metabolism of Zidovudine can be decreased when combined with Methoxsalen.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Zidovudine.]
[C03AA08, methyclothiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Zidovudine.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Methyldopa.]
[V04CG05, methylene blue, The metabolism of Zidovudine can be decreased when combined with Methylene blue.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Methylprednisolone.]
[G03EK01, methyltestosterone, The excretion of Zidovudine can be increased when combined with Methyltestosterone.]
[A03FA01, metoclopramide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Metoclopramide.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be increased when combined with Zidovudine.]
[V04CD01, metyrapone, The metabolism of Zidovudine can be decreased when combined with Metyrapone.]
[S02AA13, miconazole, The metabolism of Zidovudine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The risk or severity of bleeding can be increased when Zidovudine is combined with Aminophenazone.]
[B01AB07, parnaparin, The risk or severity of bleeding can be increased when Parnaparin is combined with Zidovudine.]
[G03XB01, mifepristone, The serum concentration of Zidovudine can be increased when it is combined with Mifepristone.]
[B01AB10, tinzaparin, The risk or severity of bleeding can be increased when Tinzaparin is combined with Zidovudine.]
[C09CA03, valsartan, The metabolism of Zidovudine can be decreased when combined with Valsartan.]
[J01AA08, minocycline, The excretion of Zidovudine can be decreased when combined with Minocycline.]
[D11AX01, minoxidil, The metabolism of Minoxidil can be increased when combined with Zidovudine.]
[L01XX23, mitotane, The metabolism of Zidovudine can be increased when combined with Mitotane.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Mitoxantrone.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Zidovudine.]
[C01BD01, amiodarone, The metabolism of Zidovudine can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Zidovudine can be decreased when combined with Amitriptyline.]
[N02AA01, morphine, The metabolism of Morphine can be increased when combined with Zidovudine.]
[L04AB05, certolizumab pegol, The metabolism of Zidovudine can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be increased when combined with Zidovudine.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ofatumumab.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Zidovudine.]
[L04AA06, mycophenolic acid, The metabolism of Mycophenolic acid can be increased when combined with Zidovudine.]
[J05AJ01, raltegravir, The metabolism of Raltegravir can be increased when combined with Zidovudine.]
[P01BA06, amodiaquine, Zidovudine may increase the neutropenic activities of Amodiaquine.]
[G03XC01, raloxifene, The metabolism of Raloxifene can be increased when combined with Zidovudine.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Zidovudine.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Zidovudine.]
[J01CA04, amoxicillin, The excretion of Zidovudine can be decreased when combined with Amoxicillin.]
[J01CF06, nafcillin, The excretion of Zidovudine can be decreased when combined with Nafcillin.]
[V03AB15, naloxone, The metabolism of Zidovudine can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The metabolism of Naltrexone can be increased when combined with Zidovudine.]
[L04AC03, anakinra, The metabolism of Zidovudine can be increased when combined with Anakinra.]
[N06BA01, amphetamine, The metabolism of Zidovudine can be decreased when combined with Amphetamine.]
[M02AA12, naproxen, The risk or severity of bleeding can be increased when Zidovudine is combined with Naproxen.]
[A10BG01, troglitazone, The metabolism of Troglitazone can be increased when combined with Zidovudine.]
[N06AX21, duloxetine, The metabolism of Zidovudine can be decreased when combined with Duloxetine.]
[L01CD02, docetaxel, The risk or severity of adverse effects can be increased when Zidovudine is combined with Docetaxel.]
[L02BG04, letrozole, The metabolism of Zidovudine can be decreased when combined with Letrozole.]
[A10BX02, repaglinide, The metabolism of Repaglinide can be decreased when combined with Zidovudine.]
[B01AC17, tirofiban, The risk or severity of bleeding can be increased when Tirofiban is combined with Zidovudine.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Amphotericin B.]
[N06AX23, desvenlafaxine, The metabolism of Zidovudine can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[J05AB11, valacyclovir, The risk or severity of adverse effects can be increased when Valaciclovir is combined with Zidovudine.]
[M04AA03, febuxostat, The excretion of Zidovudine can be decreased when combined with Febuxostat.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Zidovudine.]
[C10AD02, niacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Niacin.]
[C08CA04, nicardipine, The metabolism of Zidovudine can be decreased when combined with Nicardipine.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Zidovudine.]
[N07BA01, nicotine, The metabolism of Zidovudine can be decreased when combined with Nicotine.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Zidovudine.]
[M02AA17, niflumic acid, The risk or severity of bleeding can be increased when Zidovudine is combined with Niflumic acid.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Norfloxacin.]
[C02KX01, bosentan, The metabolism of Zidovudine can be increased when combined with Bosentan.]
[R05DA07, noscapine, The metabolism of Zidovudine can be decreased when combined with Noscapine.]
[B01AC16, eptifibatide, The risk or severity of bleeding can be increased when Eptifibatide is combined with Zidovudine.]
[B01AB08, reviparin, The risk or severity of bleeding can be increased when Reviparin is combined with Zidovudine.]
[S02AA16, ofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ofloxacin.]
[L04AC04, rilonacept, The metabolism of Zidovudine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, Omeprazole may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[B01AD07, reteplase, The risk or severity of bleeding can be increased when Reteplase is combined with Zidovudine.]
[B01AD09, ancrod, The risk or severity of bleeding can be increased when Ancrod is combined with Zidovudine.]
[C01AC01, ouabain, The excretion of Zidovudine can be decreased when combined with Ouabain.]
[A14AA08, oxandrolone, The metabolism of Zidovudine can be decreased when combined with Oxandrolone.]
[S01BC02, oxyphenbutazone, The risk or severity of bleeding can be increased when Zidovudine is combined with Oxyphenbutazone.]
[S01AA04, oxytetracycline, The excretion of Oxytetracycline can be decreased when combined with Zidovudine.]
[V04CH30, 4-aminohippuric acid, The excretion of Zidovudine can be decreased when combined with Aminohippuric acid.]
[B01AB09, danaparoid, The risk or severity of bleeding can be increased when Danaparoid is combined with Zidovudine.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Paramethasone.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Penicillamine.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Zidovudine.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Zidovudine.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Zidovudine.]
[N05CA01, pentobarbital, The metabolism of Zidovudine can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Pentostatin.]
[C04AD03, pentoxifylline, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Zidovudine.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Zidovudine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Zidovudine.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Phenindione is combined with Zidovudine.]
[N03AA02, phenobarbital, The metabolism of Zidovudine can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Zidovudine.]
[M02AA01, phenylbutazone, The risk or severity of bleeding can be increased when Zidovudine is combined with Phenylbutazone.]
[N03AB02, phenytoin, The metabolism of Phenytoin can be decreased when combined with Zidovudine.]
[L04AB06, golimumab, The metabolism of Zidovudine can be increased when combined with Golimumab.]
[N07BB03, acamprosate, The excretion of Acamprosate can be decreased when combined with Zidovudine.]
[J05AB12, cidofovir, The excretion of Zidovudine can be decreased when combined with Cidofovir.]
[S01EB01, pilocarpine, The metabolism of Zidovudine can be decreased when combined with Pilocarpine.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be increased when combined with Zidovudine.]
[J01CA12, piperacillin, The excretion of Piperacillin can be decreased when combined with Zidovudine.]
[J05AE01, saquinavir, The metabolism of Zidovudine can be decreased when combined with Saquinavir.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Eprosartan.]
[S01BC06, piroxicam, The risk or severity of bleeding can be increased when Zidovudine is combined with Piroxicam.]
[J05AG02, delavirdine, The metabolism of Zidovudine can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Zidovudine can be decreased when combined with Irbesartan.]
[B01AC13, abciximab, The risk or severity of bleeding can be increased when Abciximab is combined with Zidovudine.]
[D05AX05, tazarotene, The metabolism of Tazarotene can be decreased when combined with Zidovudine.]
[S01XA13, alteplase, The risk or severity of bleeding can be increased when Alteplase is combined with Zidovudine.]
[A10BG02, rosiglitazone, The metabolism of Zidovudine can be decreased when combined with Rosiglitazone.]
[L02BG03, anastrozole, The metabolism of Anastrozole can be decreased when combined with Zidovudine.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Zidovudine.]
[L04AC08, canakinumab, The metabolism of Zidovudine can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The excretion of Polythiazide can be decreased when combined with Zidovudine.]
[J05AE03, ritonavir, The serum concentration of Zidovudine can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The excretion of Saxagliptin can be decreased when combined with Zidovudine.]
[C10AA08, pitavastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Pitavastatin.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Prednisolone.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Prednisone.]
[P01BA03, primaquine, The metabolism of Zidovudine can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Zidovudine can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Zidovudine can be decreased when combined with Probenecid.]
[C01BA02, procainamide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Procainamide.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Procarbazine.]
[C10AB05, fenofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Fenofibrate.]
[G03DA04, progesterone, Progesterone may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N05AA03, promazine, The metabolism of Zidovudine can be decreased when combined with Promazine.]
[R06AD02, promethazine, The metabolism of Zidovudine can be decreased when combined with Promethazine.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Zidovudine.]
[N01AX10, propofol, The metabolism of Propofol can be increased when combined with Zidovudine.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Zidovudine is combined with Propylthiouracil.]
[B01AC09, epoprostenol, The risk or severity of bleeding can be increased when Epoprostenol is combined with Zidovudine.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Zidovudine.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Zidovudine.]
[P01BD01, pyrimethamine, The metabolism of Zidovudine can be decreased when combined with Pyrimethamine.]
[C01BA01, quinidine, The excretion of Zidovudine can be decreased when combined with Quinidine.]
[P01BC01, quinine, The metabolism of Zidovudine can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The excretion of Ranitidine can be decreased when combined with Zidovudine.]
[J05AP01, ribavirin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ribavirin.]
[S01XA26, riboflavin, The excretion of Zidovudine can be decreased when combined with Riboflavin.]
[J04AB02, rifampin, The metabolism of Zidovudine can be increased when combined with Rifampicin.]
[N02BA05, salicylamide, The risk or severity of bleeding can be increased when Zidovudine is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of bleeding can be increased when Zidovudine is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of bleeding can be increased when Zidovudine is combined with Salicylic acid.]
[N05CA06, secobarbital, The metabolism of Zidovudine can be increased when combined with Secobarbital.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Zidovudine.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Obinutuzumab.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Zidovudine.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Zidovudine.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Zidovudine.]
[C03DA01, spironolactone, The metabolism of Zidovudine can be decreased when combined with Spironolactone.]
[N03AG01, valproic acid, The serum concentration of Zidovudine can be increased when it is combined with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Zidovudine is combined with Hydrocortisone butyrate.]
